More AI Slop Science for Money
Springer Nature's “ratatestes” contender shows this is all a financial game now
Sing to me again the song you sing about “research integrity,” Springer Nature.
Sing to me about how “ensuring integrity is at the heart of the way we operate across the whole of Springer Nature.”
Sing about the “multiple integrity checks that are built into the editorial and publishing process.”
Sing to me about the “1.2million highly skilled independent reviewers, who are experts in their field, to assess the quality and integrity of scholarly work.”
- Also, typo — need a space between “1.2” and “million.”
- Details, details . . .
While you’re at it, sing to me about your Schuldscheindarlehen — your “debut in the debt capital market” with €500 million available with maturities from 3-5 years, and how proud you are of this accomplishment despite a Fitch rating (BBB-) just north of “speculative with substantial risk.”
- Also, sing to me about this portion of that Fitch assessment:
OA Potentially More Profitable: Springer Nature has been using transformative agreements to gradually transition its subscription revenue into OA. Currently, 27% of research revenue comes from a pure OA model. We see margin upside for Springer Nature from using this revenue model, as observed revenue per article is higher than under the subscription model, while the cost base remains unchanged.
And then sing to me about how an OA paper (price, €2,490) about autism “written” by an inexpert student at a media vocational college got through your editorial filters to be published on Wednesday, November 19th.